Coordinating Center for Continuation of Follow-Up of DES-Exposed Cohorts

This solicitation seeks proposals for a coordinating center to continue follow-up of cohorts exposed to diethylstilbestrol (DES). The National Cancer Institute within the Department of Health and Human Services requires services including coordination of blood collection from cohort members, maintenance of study files, and transfer of data. Proposals are due by December 23, 2020 and must include separate budgets and plans for an initial phase-in period, five one-year option periods including an option for blood collection from up to 1,000 participants, and a phase-out transition. The government will evaluate proposals based on technical approach, management plan, staff qualifications, and price.

There is no set-aside designation. The primary NAICS code is 541715 and PSC code R425. The incumbent contractor is unknown. The base period of performance is one year starting July 9, 2021 with four additional one-year options and a phase-out transition. The government estimates 1,826 labor hours will be required over the life of the contract. Blood collection is to be coordinated from sites in Chicago, Illinois and Boston, Massachusetts.